RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Revenue growth (%)

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Dec 31, 20243.7-157.61%
Dec 31, 2023-6.4-295.15%
Dec 31, 20223.3-85.46%
Dec 31, 202122.7-39.80%
Dec 31, 202037.7+2300.64%
Dec 31, 20191.6-90.24%
Dec 31, 201816.1+59.84%
Dec 31, 201710.1-17.27%
Dec 31, 201612.2-16.25%
Dec 31, 201514.5+133.07%
Dec 31, 20146.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)